Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

SHA:600529 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,372	17,101	16,989	18,847	26,119	29,838
Market Cap Growth	-18.09%	0.66%	-9.86%	-27.84%	-12.46%	81.44%
Enterprise Value	10,855	14,307	14,571	18,195	25,062	28,533
Last Close Price	20.15	25.08	24.25	26.60	40.67	46.01
PE Ratio	17.49	18.14	21.90	30.48	44.19	52.86
Forward PE	15.62	15.24	17.24	22.72	39.31	44.19
PS Ratio	2.84	3.34	3.41	4.50	6.74	8.71
PB Ratio	1.64	2.14	2.26	2.71	5.59	7.01
P/TBV Ratio	1.69	2.20	2.33	2.81	5.84	7.36
P/FCF Ratio	46.76	33.06	45.13	-	-	968.41
P/OCF Ratio	15.50	14.68	16.21	74.66	34.81	52.72
EV/Sales Ratio	2.31	2.79	2.93	4.35	6.47	8.33
EV/EBITDA Ratio	8.31	10.10	12.41	18.99	27.27	32.45
EV/EBIT Ratio	12.39	13.87	17.17	27.45	36.94	43.14
EV/FCF Ratio	37.96	27.66	38.71	-	-	926.06
Debt / Equity Ratio	-	-	0	0.00	-	-
Debt / EBITDA Ratio	-	-	0.00	0.01	-	-
Debt / FCF Ratio	-	-	0.01	-	-	-
Asset Turnover	0.47	0.53	0.55	0.55	0.64	0.64
Inventory Turnover	2.29	3.05	3.20	2.96	3.43	3.30
Quick Ratio	2.52	2.26	2.54	2.27	1.43	1.77
Current Ratio	3.61	2.99	3.21	3.02	1.99	2.41
Return on Equity (ROE)	9.60%	12.13%	10.70%	10.63%	13.24%	13.90%
Return on Assets (ROA)	5.52%	6.63%	5.86%	5.45%	7.05%	7.66%
Return on Invested Capital (ROIC)	13.56%	17.39%	15.43%	14.48%	18.27%	21.80%
Return on Capital Employed (ROCE)	10.60%	12.70%	11.20%	9.40%	14.30%	15.30%
Earnings Yield	5.72%	5.51%	4.57%	3.28%	2.26%	1.89%
FCF Yield	2.14%	3.02%	2.22%	-2.43%	-0.22%	0.10%
Dividend Yield	2.95%	2.47%	1.65%	1.13%	0.74%	0.65%
Payout Ratio	74.43%	49.26%	25.66%	28.87%	30.20%	31.62%
Buyback Yield / Dilution	-0.15%	-0.15%	-10.46%	-0.54%	-0.49%	0.26%
Total Shareholder Return	2.80%	2.32%	-8.81%	0.59%	0.25%	0.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.